Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Bruker Cellular Analysis, Inc.
Report date January 12, 2021 · Filed January 15, 2021
Jointly reported with WIIG Communications Management LLC, TAN LIP BU, WRV-BLI II LLC, WRV-BLI III LLC, WRV-BLI IV LLC, Walden Riverwood GP, LLC, Walden Riverwood Ventures, L.P., WRV GP II, LLC, WRV II, L.P.
Section 16 reporting ended · disclosed 2021-01-15. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 0 |
Reported balance
After 2021-01-12 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2021-01-12 · Other · Disposed 12,276,309 · Balance 0 F1: Reflects a pro rata distribution in-kind of the shares formerly held of record by the Reporting Persons to the Reporting Persons' limited partners and or members, as applicable. F2: Mr. Lip-Bu Tan is the sole director of WIIG Communications Management LLC ("WIIG") which is the manager of WRV-BLI LLC, WRV-BLI II LLC, WRV-BLI III LLC, and WRV-BLI IV LLC. Michael Marks and Mr. Tan are members of the investment committee of Walden Riverwood GP, LLC ("Walden GP"), which is the general partner of Walden Riverwood Ventures, L.P. Michael Marks, Nicholas Brathwaite, and Lip-Bu Tan are members of the investment committee of WRV GP II, LLC ("WRV GP") which is the general partner of WRV II, L.P. Messers. Tan, Brathwaite, and Marks, WRV GP, Walden GP, and WIIG disclaim beneficial ownership of the shares except to the extent of their pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects a pro rata distribution in-kind of the shares formerly held of record by the Reporting Persons to the Reporting Persons' limited partners and or members, as applicable.
F2: Mr. Lip-Bu Tan is the sole director of WIIG Communications Management LLC ("WIIG") which is the manager of WRV-BLI LLC, WRV-BLI II LLC, WRV-BLI III LLC, and WRV-BLI IV LLC. Michael Marks and Mr. Tan are members of the investment committee of Walden Riverwood GP, LLC ("Walden GP"), which is the general partner of Walden Riverwood Ventures, L.P. Michael Marks, Nicholas Brathwaite, and Lip-Bu Tan are members of the investment committee of WRV GP II, LLC ("WRV GP") which is the general partner of WRV II, L.P. Messers. Tan, Brathwaite, and Marks, WRV GP, Walden GP, and WIIG disclaim beneficial ownership of the shares except to the extent of their pecuniary interest therein.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 12, 2021 Filed Jan 15, 2021 18:31 UTC | Bruker Cellular Analysis, Inc. BLI · Entity 109250 | OtherCommon Stock | 12,276,309 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-002209 · doc4.xml · nonDerivative · entry 1 WIIG Communications Management LLC · CIK 0001339189 · 10% owner TAN LIP BU · CIK 0001008463 · 10% owner WRV-BLI LLC · CIK 0001616012 · 10% owner WRV-BLI II LLC · CIK 0001641650 · 10% owner WRV-BLI III LLC · CIK 0001687537 · 10% owner WRV-BLI IV LLC · CIK 0001817981 · 10% owner Walden Riverwood GP, LLC · CIK 0001720734 · 10% owner Walden Riverwood Ventures, L.P. · CIK 0001582026 · 10% owner WRV GP II, LLC · CIK 0001720730 · 10% owner WRV II, L.P. · CIK 0001640661 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · kind: Reflects a pro rata distribution in-kind of the shares formerly held of record by the Reporting Persons to the Reporting Persons' limited partners and or members, as applicable. F2 · ownership.nature: Mr. Lip-Bu Tan is the sole director of WIIG Communications Management LLC ("WIIG") which is the manager of WRV-BLI LLC, WRV-BLI II LLC, WRV-BLI III LLC, and WRV-BLI IV LLC. Michael Marks and Mr. Tan are members of the investment committee of Walden Riverwood GP, LLC ("Walden GP"), which is the general partner of Walden Riverwood Ventures, L.P. Michael Marks, Nicholas Brathwaite, and Lip-Bu Tan are members of the investment committee of WRV GP II, LLC ("WRV GP") which is the general partner of WRV II, L.P. Messers. Tan, Brathwaite, and Marks, WRV GP, Walden GP, and WIIG disclaim beneficial ownership of the shares except to the extent of their pecuniary interest therein. Read SEC document |
| December 10, 2020 Filed Dec 18, 2020 20:31 UTC | Bruker Cellular Analysis, Inc. BLI · Entity 109250 | SaleCommon Stock | 183,018 | $82.56 | $15,109,966.08 |
DisclosureSEC source: 0000899243-20-034554 · doc4.xml · nonDerivative · entry 1 WIIG Communications Management LLC · CIK 0001339189 · 10% owner TAN LIP BU · CIK 0001008463 · 10% owner WRV-BLI LLC · CIK 0001616012 · 10% owner WRV-BLI II LLC · CIK 0001641650 · 10% owner WRV-BLI III LLC · CIK 0001687537 · 10% owner WRV-BLI IV LLC · CIK 0001817981 · 10% owner Walden Riverwood GP, LLC · CIK 0001720734 · 10% owner Walden Riverwood Ventures, L.P. · CIK 0001582026 · 10% owner WRV GP II, LLC · CIK 0001720730 · 10% owner WRV II, L.P. · CIK 0001640661 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 12,276,309 F1 · ownership.nature: Following the transactions reported herein, consist of 839,782 shares held by WRV II, L.P. ("WRV II"), 2,860,225 shares held by Walden Riverwood Ventures, L.P. ("Walden"), 5,459,969 shares held by WRV-BLI LLC ("BLI"), 1,760,067 shares held by WRV-BLI II LLC ("BLI II"), 867,473 shares held by WRV-BLI III LLC ("BLI III"), and 488,793 shares held by WRV-BLI IV LLC ("BLI IV"). F2 · ownership.nature: Mr. Lip-Bu Tan is the sole director of WIIG Communications Management LLC ("WIIG") which is the manager of BLI, BLI II, BLI III, and BLI IV. Michael Marks and Mr. Tan are members of the investment committee of Walden Riverwood GP, LLC ("Walden GP"), which is the general partner of Walden. Michael Marks, Nicholas Brathwaite, and Lip-Bu Tan are members of the investment committee of WRV GP II, LLC ("WRV GP") which is the general partner of WRV II. Messers. Tan, Brathwaite, and Marks, WRV GP, Walden GP, and WIIG disclaim beneficial ownership of the shares except to the extent of their pecuniary interest therein. Read SEC document |
| November 23, 2020 Filed Nov 25, 2020 14:10 UTC | Bruker Cellular Analysis, Inc. BLI · Entity 109250 | SaleCommon Stock | 1,203,029 | $82.56 | $99,322,074.24 |
DisclosureSEC source: 0000899243-20-032134 · doc4.xml · nonDerivative · entry 1 WIIG Communications Management LLC · CIK 0001339189 · 10% owner TAN LIP BU · CIK 0001008463 · 10% owner WRV-BLI LLC · CIK 0001616012 · 10% owner WRV-BLI II LLC · CIK 0001641650 · 10% owner WRV-BLI III LLC · CIK 0001687537 · 10% owner WRV-BLI IV LLC · CIK 0001817981 · 10% owner Walden Riverwood GP, LLC · CIK 0001720734 · 10% owner Walden Riverwood Ventures, L.P. · CIK 0001582026 · 10% owner WRV GP II, LLC · CIK 0001720730 · 10% owner WRV II, L.P. · CIK 0001640661 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 12,459,328 F1 · ownership.nature: Following the transactions reported herein, consist of 852,302 shares held by WRV II, L.P. ("WRV II"), 2,902,867 shares held by Walden Riverwood Ventures, L.P. ("Walden"), 5,541,366 shares held by WRV-BLI LLC ("BLI"), 1,786,307 shares held by WRV-BLI II LLC ("BLI II"), 880,405 shares held by WRV-BLI III LLC ("BLI III"), and 496,081 shares held by WRV-BLI IV LLC ("BLI IV"). F2 · ownership.nature: Mr. Lip-Bu Tan is the sole director of WIIG Communications Management LLC ("WIIG") which is the manager of BLI, BLI II, BLI III, and BLI IV. Michael Marks and Mr. Tan are members of the investment committee of Walden Riverwood GP, LLC ("Walden GP"), which is the general partner of Walden. Michael Marks, Nicholas Brathwaite, and Lip-Bu Tan are members of the investment committee of WRV GP II, LLC ("WRV GP") which is the general partner of WRV II. Messers. Tan, Brathwaite, and Marks, WRV GP, Walden GP, and WIIG disclaim beneficial ownership of the shares except to the extent of their pecuniary interest therein. Read SEC document |
| July 16, 2020 Filed Jul 20, 2020 21:50 UTC | Bruker Cellular Analysis, Inc. BLI · Entity 109250 | ConversionSeries E Preferred Stock · Derivative | 735,635 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-019738 · doc4.xml · derivative · entry 5 WIIG Communications Management LLC · CIK 0001339189 · 10% owner TAN LIP BU · CIK 0001008463 · 10% owner WRV-BLI LLC · CIK 0001616012 · 10% owner WRV-BLI II LLC · CIK 0001641650 · 10% owner WRV-BLI III LLC · CIK 0001687537 · 10% owner WRV-BLI IV LLC · CIK 0001817981 · 10% owner Walden Riverwood GP, LLC · CIK 0001720734 · 10% owner Walden Riverwood Ventures, L.P. · CIK 0001582026 · 10% owner WRV GP II, LLC · CIK 0001720730 · 10% owner WRV II, L.P. · CIK 0001640661 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 735,635 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Preferred Stock automatically converted on a one-for-one basis into Common stock upon the closing of the Issuer's initial public offering. F1 · derivative.exercise_date: Each share of Preferred Stock automatically converted on a one-for-one basis into Common stock upon the closing of the Issuer's initial public offering. F1 · derivative.expiration_date: Each share of Preferred Stock automatically converted on a one-for-one basis into Common stock upon the closing of the Issuer's initial public offering. F3 · ownership.nature: Mr. Lip-Bu Tan is the sole director of WIIG Communications Management LLC ("WIIG") which is the manager of BLI, BLI II, BLI III, and BLI IV. Michael Marks, Nicholas Brathwaite and Mr. Tan are members of the investment committee of Walden Riverwood GP, LLC ("Walden GP"), which is the general partner of Walden. WRV GP II, LLC ("WRV GP") is the general partner of WRV II. Messers. Tan and Marks, WRV GP, Walden GP, and WIIG disclaim beneficial ownership of the shares except to the extent of their pecuniary interest therein. Read SEC document |
| July 16, 2020 Filed Jul 20, 2020 21:50 UTC | Bruker Cellular Analysis, Inc. BLI · Entity 109250 | ConversionSeries D Preferred Stock · Derivative | 1,708,356 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-019738 · doc4.xml · derivative · entry 4 WIIG Communications Management LLC · CIK 0001339189 · 10% owner TAN LIP BU · CIK 0001008463 · 10% owner WRV-BLI LLC · CIK 0001616012 · 10% owner WRV-BLI II LLC · CIK 0001641650 · 10% owner WRV-BLI III LLC · CIK 0001687537 · 10% owner WRV-BLI IV LLC · CIK 0001817981 · 10% owner Walden Riverwood GP, LLC · CIK 0001720734 · 10% owner Walden Riverwood Ventures, L.P. · CIK 0001582026 · 10% owner WRV GP II, LLC · CIK 0001720730 · 10% owner WRV II, L.P. · CIK 0001640661 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 1,708,356 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Preferred Stock automatically converted on a one-for-one basis into Common stock upon the closing of the Issuer's initial public offering. F1 · derivative.exercise_date: Each share of Preferred Stock automatically converted on a one-for-one basis into Common stock upon the closing of the Issuer's initial public offering. F1 · derivative.expiration_date: Each share of Preferred Stock automatically converted on a one-for-one basis into Common stock upon the closing of the Issuer's initial public offering. F3 · ownership.nature: Mr. Lip-Bu Tan is the sole director of WIIG Communications Management LLC ("WIIG") which is the manager of BLI, BLI II, BLI III, and BLI IV. Michael Marks, Nicholas Brathwaite and Mr. Tan are members of the investment committee of Walden Riverwood GP, LLC ("Walden GP"), which is the general partner of Walden. WRV GP II, LLC ("WRV GP") is the general partner of WRV II. Messers. Tan and Marks, WRV GP, Walden GP, and WIIG disclaim beneficial ownership of the shares except to the extent of their pecuniary interest therein. Read SEC document |
| July 16, 2020 Filed Jul 20, 2020 21:50 UTC | Bruker Cellular Analysis, Inc. BLI · Entity 109250 | ConversionSeries C Preferred Stock · Derivative | 2,812,029 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-019738 · doc4.xml · derivative · entry 3 WIIG Communications Management LLC · CIK 0001339189 · 10% owner TAN LIP BU · CIK 0001008463 · 10% owner WRV-BLI LLC · CIK 0001616012 · 10% owner WRV-BLI II LLC · CIK 0001641650 · 10% owner WRV-BLI III LLC · CIK 0001687537 · 10% owner WRV-BLI IV LLC · CIK 0001817981 · 10% owner Walden Riverwood GP, LLC · CIK 0001720734 · 10% owner Walden Riverwood Ventures, L.P. · CIK 0001582026 · 10% owner WRV GP II, LLC · CIK 0001720730 · 10% owner WRV II, L.P. · CIK 0001640661 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 2,812,029 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Preferred Stock automatically converted on a one-for-one basis into Common stock upon the closing of the Issuer's initial public offering. F1 · derivative.exercise_date: Each share of Preferred Stock automatically converted on a one-for-one basis into Common stock upon the closing of the Issuer's initial public offering. F1 · derivative.expiration_date: Each share of Preferred Stock automatically converted on a one-for-one basis into Common stock upon the closing of the Issuer's initial public offering. F3 · ownership.nature: Mr. Lip-Bu Tan is the sole director of WIIG Communications Management LLC ("WIIG") which is the manager of BLI, BLI II, BLI III, and BLI IV. Michael Marks, Nicholas Brathwaite and Mr. Tan are members of the investment committee of Walden Riverwood GP, LLC ("Walden GP"), which is the general partner of Walden. WRV GP II, LLC ("WRV GP") is the general partner of WRV II. Messers. Tan and Marks, WRV GP, Walden GP, and WIIG disclaim beneficial ownership of the shares except to the extent of their pecuniary interest therein. Read SEC document |
| July 16, 2020 Filed Jul 20, 2020 21:50 UTC | Bruker Cellular Analysis, Inc. BLI · Entity 109250 | ConversionSeries B Preferred Stock · Derivative | 8,406,337 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-019738 · doc4.xml · derivative · entry 2 WIIG Communications Management LLC · CIK 0001339189 · 10% owner TAN LIP BU · CIK 0001008463 · 10% owner WRV-BLI LLC · CIK 0001616012 · 10% owner WRV-BLI II LLC · CIK 0001641650 · 10% owner WRV-BLI III LLC · CIK 0001687537 · 10% owner WRV-BLI IV LLC · CIK 0001817981 · 10% owner Walden Riverwood GP, LLC · CIK 0001720734 · 10% owner Walden Riverwood Ventures, L.P. · CIK 0001582026 · 10% owner WRV GP II, LLC · CIK 0001720730 · 10% owner WRV II, L.P. · CIK 0001640661 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 8,406,337 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Preferred Stock automatically converted on a one-for-one basis into Common stock upon the closing of the Issuer's initial public offering. F1 · derivative.exercise_date: Each share of Preferred Stock automatically converted on a one-for-one basis into Common stock upon the closing of the Issuer's initial public offering. F1 · derivative.expiration_date: Each share of Preferred Stock automatically converted on a one-for-one basis into Common stock upon the closing of the Issuer's initial public offering. F3 · ownership.nature: Mr. Lip-Bu Tan is the sole director of WIIG Communications Management LLC ("WIIG") which is the manager of BLI, BLI II, BLI III, and BLI IV. Michael Marks, Nicholas Brathwaite and Mr. Tan are members of the investment committee of Walden Riverwood GP, LLC ("Walden GP"), which is the general partner of Walden. WRV GP II, LLC ("WRV GP") is the general partner of WRV II. Messers. Tan and Marks, WRV GP, Walden GP, and WIIG disclaim beneficial ownership of the shares except to the extent of their pecuniary interest therein. Read SEC document |
| July 16, 2020 Filed Jul 20, 2020 21:50 UTC | Bruker Cellular Analysis, Inc. BLI · Entity 109250 | ConversionCommon Stock | 13,662,357 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-019738 · doc4.xml · nonDerivative · entry 1 WIIG Communications Management LLC · CIK 0001339189 · 10% owner TAN LIP BU · CIK 0001008463 · 10% owner WRV-BLI LLC · CIK 0001616012 · 10% owner WRV-BLI II LLC · CIK 0001641650 · 10% owner WRV-BLI III LLC · CIK 0001687537 · 10% owner WRV-BLI IV LLC · CIK 0001817981 · 10% owner Walden Riverwood GP, LLC · CIK 0001720734 · 10% owner Walden Riverwood Ventures, L.P. · CIK 0001582026 · 10% owner WRV GP II, LLC · CIK 0001720730 · 10% owner WRV II, L.P. · CIK 0001640661 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 13,662,357 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Preferred Stock automatically converted on a one-for-one basis into Common stock upon the closing of the Issuer's initial public offering. F2 · ownership.nature: Following the transactions reported herein, consist of 934,597 shares held by WRV II, L.P. ("WRV II"), 3,183,158 shares held by Walden Riverwood Ventures, L.P. ("Walden"), 6,076,421 shares held by WRV-BLI LLC ("BLI"), 1,958,787 shares held by WRV-BLI II LLC ("BLI II"), 965,414 shares held by WRV-BLI III LLC ("BLI III"), and 543,980 shares held by WRV-BLI IV LLC ("BLI IV"). F3 · ownership.nature: Mr. Lip-Bu Tan is the sole director of WIIG Communications Management LLC ("WIIG") which is the manager of BLI, BLI II, BLI III, and BLI IV. Michael Marks, Nicholas Brathwaite and Mr. Tan are members of the investment committee of Walden Riverwood GP, LLC ("Walden GP"), which is the general partner of Walden. WRV GP II, LLC ("WRV GP") is the general partner of WRV II. Messers. Tan and Marks, WRV GP, Walden GP, and WIIG disclaim beneficial ownership of the shares except to the extent of their pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.